Cargando…

Mipomersen in Familial Hypercholesterolemia: An Update on Health-Related Quality of Life and Patient-Reported Outcomes

Familial hypercholesterolemia (FH) is an autosomal dominant condition that leads to significantly elevated low-density lipoprotein cholesterol (LDL-C) levels and an elevated risk for cardiovascular disease. Mipomersen is an antisense oligonucleotide inhibitor targeted to apolipoprotein B-100 (apoB-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chambergo-Michilot, Diego, Alur, Anish, Kulkarni, Saneel, Agarwala, Anandita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880726/ https://www.ncbi.nlm.nih.gov/pubmed/35221690 http://dx.doi.org/10.2147/VHRM.S191965

Ejemplares similares

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
por: Bell, Damon A, et al.
Publicado: (2012)

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2012)

The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials
por: Astaneh, Behrooz, et al.
Publicado: (2021)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
por: Agarwala, Anandita, et al.
Publicado: (2021)

Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
por: McGowan, Mary P., et al.
Publicado: (2012)

Associations between chronic conditions and oral health services utilization in older Peruvian adults: a pooled analysis of the Demographic and Health Survey 2015-2017
por: Azañedo, Diego, et al.
Publicado: (2020)

Effects and safety of SGLT2 inhibitors compared to placebo in patients with heart failure: A systematic review and meta-analysis
por: Chambergo-Michilot, Diego, et al.
Publicado: (2020)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

Temporal arteritis, Sjögren’s syndrome and mixed pain components as manifestations in a diabetic older adult: systematic review based on a case report
por: Runzer-Colmenares, Fernando M., et al.
Publicado: (2020)

Acute pulmonary histoplasmosis related to occupational roofing: A case report of two brothers
por: Gnoni, Martin, et al.
Publicado: (2021)

Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
por: Santos, Raul D., et al.
Publicado: (2015)

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
por: Agarwala, Anandita, et al.
Publicado: (2021)

Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
por: Schaefer, Esperance A K, et al.
Publicado: (2016)

Discontinuation of Antihypertensive Drug Use Compared to Continuation in COVID-19 Patients: A Systematic Review with Meta-analysis and Trial Sequential Analysis
por: Chambergo-Michilot, Diego, et al.
Publicado: (2023)

Homozygous familial hypercholesterolemia with an update on cholesterol management
por: Velvet, Anju J J, et al.
Publicado: (2020)

Familial hypercholesterolemia – treatment update in children, systematic review
por: Ziółkowska, Sabina, et al.
Publicado: (2022)

Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country
por: Valcarcel, Bryan, et al.
Publicado: (2023)

Association between Eating Patterns and Quality of Life in Patients with Familial Hypercholesterolemia
por: Maștaleru, Alexandra, et al.
Publicado: (2023)

Clinical characteristics, management, and outcomes of patients with primary cardiac angiosarcoma: A systematic review
por: Chambergo-Michilot, Diego, et al.
Publicado: (2023)

Socioeconomic determinants of hypertension and prehypertension in Peru: Evidence from the Peruvian Demographic and Health Survey
por: Chambergo-Michilot, Diego, et al.
Publicado: (2021)

Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro(®)): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
por: Geary, Richard S., et al.
Publicado: (2015)

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
por: Lee, Sang-Hak
Publicado: (2017)

Recent Advances in Gene Therapy for Familial Hypercholesterolemia: An Update Review
por: Fu, Qingan, et al.
Publicado: (2022)

Changes in Mipomersen Dosing Regimen Provide Similar Exposure With Improved Tolerability in Randomized Placebo‐Controlled Study of Healthy Volunteers
por: Flaim, JoAnn D., et al.
Publicado: (2014)

Text message reminders for improving sun protection habits: A systematic review
por: Chambergo-Michilot, Diego, et al.
Publicado: (2020)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Quality Assessment of the Genetic Test for Familial Hypercholesterolemia in The Netherlands
por: Kindt, Iris, et al.
Publicado: (2013)

Trends and geographical variation in mortality from coronary disease in Peru
por: Chambergo-Michilot, Diego, et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Familial hypercholesterolemia: A review
por: Varghese, Mithun J
Publicado: (2014)

Familial Hypercholesterolemia and the Atherosclerotic Disease
por: Kim, Yoo Ri, et al.
Publicado: (2013)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Tendinous xanthoma with familial hypercholesterolemia
por: Roy, Alok Kumar, et al.
Publicado: (2014)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Familial hypercholesterolemia: The skin speaks
por: Johnson, Johns T., et al.
Publicado: (2020)

Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ip1kir5remsqhihmg27l1bkneh